<code id='EFC4F461EC'></code><style id='EFC4F461EC'></style>
    • <acronym id='EFC4F461EC'></acronym>
      <center id='EFC4F461EC'><center id='EFC4F461EC'><tfoot id='EFC4F461EC'></tfoot></center><abbr id='EFC4F461EC'><dir id='EFC4F461EC'><tfoot id='EFC4F461EC'></tfoot><noframes id='EFC4F461EC'>

    • <optgroup id='EFC4F461EC'><strike id='EFC4F461EC'><sup id='EFC4F461EC'></sup></strike><code id='EFC4F461EC'></code></optgroup>
        1. <b id='EFC4F461EC'><label id='EFC4F461EC'><select id='EFC4F461EC'><dt id='EFC4F461EC'><span id='EFC4F461EC'></span></dt></select></label></b><u id='EFC4F461EC'></u>
          <i id='EFC4F461EC'><strike id='EFC4F461EC'><tt id='EFC4F461EC'><pre id='EFC4F461EC'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:8896
          JUUL store sign -- health coverage from STAT
          Stephanie Keith/Getty Images

          Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

          Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

          advertisement

          It’s not clear how much the company ultimately spent on the partnerships.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          How many hemophilia patients actually want gene therapy?
          How many hemophilia patients actually want gene therapy?

          AdobeAsaboygrowingupwithhemophiliaA,NoahFrederickreservedtheendofhisannualcheckupstotalkaboutnewtech

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          BridgeBio heart drug succeeds in pivotal study

          AdobeAdrugdevelopedbythebiotechfirmBridgeBiototreatanincreasinglycommonheartconditionsucceededinitsm